Literature DB >> 4026363

Maternal serum folate and vitamin B12 concentrations in pregnancies associated with neural tube defects.

A M Molloy, P Kirke, I Hillary, D G Weir, J M Scott.   

Abstract

Serum folate and vitamin B12 concentrations in early pregnancy were compared for 32 mothers with pregnancies affected by neural tube defects and 395 randomly selected pregnant control women from the same maternity hospitals. No significant differences were found between the affected mothers and the controls in the median values and frequency distributions of either vitamin. Sixteen of the samples from mothers whose infants had neural tube defects were taken between 9 and 13 weeks' gestation and 11 of these had both serum folate and vitamin B12 concentrations within the normal ranges for our laboratory. These findings are discussed in relation to the concept of folate deficiency as a major factor in the aetiology of neural tube defects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026363      PMCID: PMC1777297          DOI: 10.1136/adc.60.7.660

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  Comparison of results of microbiologic and radioisotopic assays for serum vitamin B12 during pregnancy.

Authors:  R Green; N Colman; J Metz
Journal:  Am J Obstet Gynecol       Date:  1975-05-01       Impact factor: 8.661

2.  Folic acid deficiency and congenital malformation.

Authors:  M H Hall
Journal:  J Obstet Gynaecol Br Commonw       Date:  1972-02

3.  Vitamin B12 and anencephaly.

Authors:  C J Schorah; R W Smithells; J Scott
Journal:  Lancet       Date:  1980-04-19       Impact factor: 79.321

4.  Folate balance in dietary-induced megaloblastic anemia.

Authors:  E R Eichner; H I Pierce; R S Hillman
Journal:  N Engl J Med       Date:  1971-04-29       Impact factor: 91.245

5.  Folates and the fetus.

Authors:  M H Hall
Journal:  Lancet       Date:  1977-03-19       Impact factor: 79.321

6.  Erythrocyte, plasma, and serum folate: specimen stability before microbiological assay.

Authors:  J D O'Broin; I J Temperley; J M Scott
Journal:  Clin Chem       Date:  1980-03       Impact factor: 8.327

7.  Trouble-free microbiologic serum and red cell folate assays.

Authors:  J M Scott; V Ghanta; V Herbert
Journal:  Am J Med Technol       Date:  1974-03

8.  Vitamin deficiencies and neural tube defects.

Authors:  R W Smithells; S Sheppard; C J Schorah
Journal:  Arch Dis Child       Date:  1976-12       Impact factor: 3.791

9.  Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects.

Authors:  K M Laurence; N James; M H Miller; G B Tennant; H Campbell
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-09

10.  Possible prevention of neural-tube defects by periconceptional vitamin supplementation.

Authors:  R W Smithells; S Sheppard; C J Schorah; M J Seller; N C Nevin; R Harris; A P Read; D W Fielding
Journal:  Lancet       Date:  1980-02-16       Impact factor: 79.321

View more
  13 in total

1.  One-Carbon Cofactor Intake and Risk of Neural Tube Defects Among Women Who Meet Folic Acid Recommendations: A Multicenter Case-Control Study.

Authors:  Julie M Petersen; Samantha E Parker; Krista S Crider; Sarah C Tinker; Allen A Mitchell; Martha M Werler
Journal:  Am J Epidemiol       Date:  2019-06-01       Impact factor: 4.897

Review 2.  Genomic approaches to the assessment of human spina bifida risk.

Authors:  M Elizabeth Ross; Christopher E Mason; Richard H Finnell
Journal:  Birth Defects Res       Date:  2017-01-30       Impact factor: 2.344

3.  Gene-environment interactions, folate metabolism and the embryonic nervous system.

Authors:  M Elizabeth Ross
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Jul-Aug

Review 4.  The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects.

Authors:  Anne M Molloy; Lawrence C Brody; James L Mills; John M Scott; Peadar N Kirke
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-04

Review 5.  Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview.

Authors:  Anna E Beaudin; Patrick J Stover
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-04

6.  Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic Acid fortification.

Authors:  Anne M Molloy; Peadar N Kirke; James F Troendle; Helen Burke; Marie Sutton; Lawrence C Brody; John M Scott; James L Mills
Journal:  Pediatrics       Date:  2009-03       Impact factor: 7.124

7.  Impact of trace mineral source on beef replacement heifer growth, reproductive development, and biomarkers of maternal recognition of pregnancy and embryo survival.

Authors:  George A Perry; Stephanie D Perkins; Emmalee J Northrop; Jerica J J Rich; Kaitlin M Epperson; Taylor N Andrews; Adalaide C Kline; Lacey K Quail; Julie A Walker; Cody L Wright; Jason R Russell
Journal:  J Anim Sci       Date:  2021-07-01       Impact factor: 3.159

8.  Maternal folate and vitamin b(12) status and neural tube defects in northern iran: a case control study.

Authors:  Elahm Mobasheri; Abbasali Keshtkar; Mohammad-Jafar Golalipour
Journal:  Iran J Pediatr       Date:  2010-06       Impact factor: 0.364

Review 9.  Vitamin B(12) metabolism during pregnancy and in embryonic mouse models.

Authors:  Maira A Moreno-Garcia; David S Rosenblatt; Loydie A Jerome-Majewska
Journal:  Nutrients       Date:  2013-09-10       Impact factor: 5.717

10.  Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals.

Authors:  Stein Emil Vollset; Robert Clarke; Sarah Lewington; Marta Ebbing; Jim Halsey; Eva Lonn; Jane Armitage; JoAnn E Manson; Graeme J Hankey; J David Spence; Pilar Galan; Kaare H Bønaa; Rex Jamison; J Michael Gaziano; Peter Guarino; John A Baron; Richard F A Logan; Edward L Giovannucci; Martin den Heijer; Per M Ueland; Derrick Bennett; Rory Collins; Richard Peto
Journal:  Lancet       Date:  2013-03-23       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.